4//SEC Filing
Schalop Lee Troy 4
Accession 0001493152-26-002026
CIK 0001763950other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:05 PM ET
Size
8.0 KB
Accession
0001493152-26-002026
Insider Transaction Report
Form 4
Schalop Lee Troy
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+25,000→ 25,000 totalExercise: $3.49Exp: 2036-01-08→ Common Stock (25,000 underlying) - Award
Stock Option (Right to Buy)
[F2]2026-01-09+18,460→ 18,460 totalExercise: $3.49Exp: 2036-01-08→ Common Stock (18,460 underlying)
Footnotes (2)
- [F1]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing February 9, 2026.
- [F2]The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 12-month period commencing February 9, 2026.
Signature
/s/ Lee T. Schalop|2026-01-12
Documents
Issuer
Lantern Pharma Inc.
CIK 0001763950
Entity typeother
Related Parties
1- filerCIK 0002072339
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:05 PM ET
- Size
- 8.0 KB